We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Removal of Colon Polyps May Not Require Resection

By HospiMedica International staff writers
Posted on 30 Jun 2014
Laparoscopic-assisted colonoscopic polypectomy (LACP) of benign polyps requires fewer resources and is just as effective as a partial colon resection.

Researchers at Stony Brook University (SBU; NY, USA) conducted a randomized study involving 34 patients with benign right-sided polyps to undergo either LACP or laparoscopic hemicolectomy (LHC). The two groups were similar in age and gender distribution, average body mass index (BMI), American Society of Anesthesiologists (ASA) class, and history of previous abdominal surgery; polyp morphology, location, size, and histology were also similar between the two groups.

The researchers found that they were able to remove polyps in 92.9% of patients assigned to LACP, with one patient requiring conversion to LHC. In the group randomized to LHC, four patients required conversion to open laparotomy. The study also found that LACP required less time than LHC (95 vs. 179 minutes), and LACP patients lost less blood (13 vs. 63 mL). LACP patients also required less intravenous (IV) fluids, took less time to pass flatus, resumed solid food intake sooner postoperatively, and were discharged earlier.

Rates of postoperative complications, hospital readmissions, and reoperations were similar among the two groups. The researchers reported that the patients in the study will continue to undergo surveillance colonoscopies to determine whether there are any differences in their long-term outcomes. The study was presented at Digestive Disease Week (DDW), held during May 2014 in Chicago (IL, USA).

“Although LACP has clear benefits, adoption of the procedure has been slow. The biggest roadblock to performing LACP is the ability of a surgeon and gastroenterologist to coordinate their schedules,” said lead author Jonathan Buscaglia, MD, director of interventional endoscopy at SBU. “You need a good relationship between the two departments, and schedules that can accommodate being in the operating room at the same time. It’s not always the easiest thing to do.”

During LACP, surgeons use a laparoscope to mobilize the right colon to a position that will allow an endoscopist to reach, snare, and remove the benign polyps. The technique is easier to perform on the right side of the colon, since the left colon presents surgeons with several obstacles, including diverticulitis, scarring, and tight anatomy.

Related Links:

Stony Brook University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
IV Therapy Cart
Avalo I.V Therapy Cart
New
Trocar
TAN RoTaLock Trocar

Channels

Critical Care

view channel
Image: Researchers have taken a major step toward cuff-free blood pressure monitoring (Photo courtesy of Gwyneth Moe/Boston University)

Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension

Hypertension affects nearly half of all adults in the U.S. and remains the leading cause of cardiovascular disease. Regular and accurate blood pressure monitoring is essential for managing this condition,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more